Sprouts Launches Bold Lawsuit Challenging Insulin Pricing
Sprouts files lawsuit over insulin pricing scheme and PBM collusion.
Athithi Verma
Regeneron Unlocks Game-Changing Multispecific Antibody Pact
Regeneron boosts its pipeline with multispecific platform for disease innovation.
Thermo Fisher’s Inspiring $10 Billion Acquisition of Clario
Thermo Fisher acquisition hits billion mark for Clario.
HAS Stroke Update Transforms Access on World Stroke Day
HAS strengthens stroke management for faster, equitable emergency care access.
NICE accelerates breakthrough framework for complex liver diseases
NICE drives innovation, reshaping MASH evaluations with transformative guidance.
Novartis secures triumphant $12 billion takeover of Avidity
The billion-dollar acquisition advances Avidity’s RNA platform with momentum.
Biogen Secures Breakthrough Edge in Immunology with $1B Vanqua Buy
Biogen strengthens Immunology pipeline through $1B Vanqua acquisition deal.
Sanofi Secures Breakthrough FDA Review for Tzield
Sanofi’s Tzield gains FDA review for stage 3 T1D.
Pfizer Throws Down $7.3B Gauntlet in Obesity Race with Metsera Buyout
After internal setbacks, Pfizer is buying its way into the obesity drug market.
Bain Capital Acquires Mitsubishi Tanabe Pharma
Bain Capital, a leading global private investment firm with approximately $160 billion in assets under management, has announced its agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC), a renowned Japanese pharmaceutical company with over 300 years of heritage. This transaction represents one of Bain Capital’s largest investments in the pharmaceutical sector and demonstrates its continued … Read more